Search

everythinglearnresearchcommunity

for

Search:↓

Greater intimacy leads to better self-reported health in couples having infertility treatment.

The 2003 consensus updated PCOS diagnosis criteria and highlighted increased risks of diabetes and heart disease for those affected.

Testing basal 17-HP levels is a good way to screen for nonclassic adrenal hyperplasia in women with high androgen levels.

Flutamide may slightly improve hair loss in women, but finasteride does not work.

Amenorrhea is relatively rare and initial testing should check FSH, TSH, and prolactin levels.

Finasteride reduces hair growth better, but spironolactone has more side effects.

Finasteride, CPA, and flutamide are all equally effective in reducing excessive hair growth in women.

Finasteride effectively reduces hair growth in women with idiopathic hirsutism, but requires careful contraception during treatment.

Diane 35 plus finasteride is more effective for treating hirsutism.

Spironolactone can reduce hair growth in women with hirsutism.

All three treatments reduce hirsutism, but spironolactone works best long-term.

Flutamide reduces hair growth better but has more side effects.

Diane 35 plus finasteride is more effective in reducing hair growth and androgen levels, but may decrease libido.

Finasteride effectively treats hirsutism in women, but more research needed for long-term results.

Women with PCOS often have hair loss, which is linked to acne or excess body hair but not to worse hormone or metabolic issues.

Longer CAG repeat lengths in the androgen receptor gene are linked to higher testosterone levels in women with PCOS.

Combination drug therapy is effective for hirsutism that doesn't improve with just one medication.

The document concludes that identifying the cause of amenorrhea is crucial for proper treatment.

More PDCD4 is linked to obesity, insulin problems, and cell death in ovaries for those with polycystic ovary syndrome.

Finasteride and flutamide both reduce hair growth, but finasteride has fewer side effects.

Amenorrhea is when a woman doesn't have periods, with primary amenorrhea starting by age 15 or within five years of breast development, and secondary amenorrhea when periods stop for three months. It affects 3-4% of women not pregnant, breastfeeding, or in menopause, mainly due to polycystic ovary syndrome, hypothalamic amenorrhea, hyperprolactinemia, and ovarian failure.

Teens with PCOS and a mom with PCOS have higher insulin resistance and lower adiponectin levels, which could signal early metabolic problems.

Amenorrhea, or the absence of periods, should be evaluated by age 15 or within five years of early breast development, and is most commonly caused by conditions like polycystic ovary syndrome and hypothalamic amenorrhea.

About 7% of Omani women visiting a gynecology clinic had polycystic ovarian syndrome, similar to rates in other countries.

Operative hysteroscopy is still the main treatment for Asherman syndrome, but more research is needed on post-surgery methods.

Nonobese, normotensive Indian women with PCOS may have a higher risk of heart problems linked to inflammation and insulin resistance.

PCOS may be influenced by factors in the blood, not just the ovaries.

A certain gene variant may increase the risk of polycystic ovary syndrome in Chinese women.

Post-finasteride syndrome's existence is uncertain; more research needed.

Birth control pills increase certain receptor activities in female gerbil prostate glands and can lead to prostate changes.